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Summary: The relationship between the concentration of the analyte and the imprecision of an analytical
method can be displayed by the precision profile in which the coefficient of variation (relative standard
deviation) is plotted against the concentration of the analyte. The function of the curve of the profile and its
confidence limits can easily be assessed by a computer program developed by W. A. Sadler & M. H. Smith
(Clin. Chem. 36 (1990), 1346 — 1350). For the assessment of limits of detection and of quantification the
following procedure is proposed:
The lower (and upper) limit of the measuring interval is defined by the point at which an acceptable CV-line
intersects the confidence limit. If, in the variance function one sets the concentration to zero, the normal
distribution of the random errors of the blank will result. The mean of the next adjacent normal distribution,
following the variance formula and overlapping the "zero-distribution" by a defined amount, represents the
limit of detection. Within the described measuring interval, or within a fraction of it, one might construct
overlapping normal distributions in an analogous manner. Their number represents the "power of definition"
(PD) (instead of the "analytical sensitivity"), which also depends on the concentration of the determinand
according to the variance function.
We tested these hypotheses by a comparison of two methods for the determination of cyclosporin A
(ciclosporin, INN). Our results demonstrate that the data of the lower limits of the measuring interval and
of the limit of detection agree well with data from the literature obtained in extensive interlaboratory surveys.
Introduction _ , r - . , . . r -Instead of this ambiguous expression, we prefer the
The three most important characteristics of the effi- term "power of definition" (PD), characterizing the
ciency of analytical methods, particularly in the field smallest difference of analyte concentration (or signal- .
of instrumental chemical analysis, are1): difference) which can be discriminated with a defined
(i) limit of detection (LD), statistical confidence.
(ii) lower (and upper) limit of the quantification in- Today, the definitions of limits for "... qualitative
terval (LLQ and ULQ respectively), and detection and quantitative determination ..." given
* C"mV? (1> *re " ««P1 · The tist of(iii) its «analytical sensitivity". r ,detection and determination deal specifically with the
- observed signal and its associated random fluctua-
') List of^atoi^ojisM^ tions> in other words w[th the anaiytiCal imprecision,
LC = Critical limit which Currie assumes to be constant (homoscedastic).
LLQ = Lower limit of quantification interval .
ULQ = Upper limit of quantification interval It: 1S a common occurrence in many analytical assays
PD = Power of definition that the distribution of random errors varies with the
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concentration of the determinand, embedded in the
test material (reviewed in I.e. (2)). This is virtually
the rule with radioimmunoassays. Thanks to the syste-
matic investigations of the dose response curves of
various immunoassays by Rodbard & Cooper (3) the
interdependence of imprecision and concentration is
commonly appreciated today.
Bayer's concept (4) of the "lower limit of an interassay
quantitative measurement" is based on this relation.
A precision profile according to Ekins (5) is con-
structed and this limit is graphically assessed "... from
the intercept of the interassay CV (y axis) equal to
10% or 15% with the precision profile curve ...".
The precision profile is an instructive graphical rep-
resentation of the intra-assay (or interassay, or inter-
laboratory etc.) coefficient of variation (CV) versus
the concentration of the analyte in an x/y diagram.
If instead of^the CV the analytical variance is plotted
against the concentration, then the shape of the curve
follows mathematically the "variance function". Rod-
bard (6), Ekins (7), and Raab (8) have developed
indirect methods for their assessment, whereas Baxter
(9), Sadler et al. (10) and Raggatt (11) have described
direct methods for their calculation.
Theoretical Considerations
Recently Sadler & Smith (12) also published a method
for computing and plotting the confidence intervals
for precision profiles. As in an earlier paper (13) the
construction of the profile is based on a three-para-
meter variance function:
a2(U) = (β, + 2U)J
where a2(U) denotes variance, U stands for concen-
tration, and β,, β2, and J are the parameters. The
confidence interval is assessed according to 1. c. (14).
Interval widths reflect both the quantity of data and
the way the data are distributed over the concentra-
tion range.
For the assessment of limits of detection and of quan-
tification the following inferences are suggested:
i) The lower (and upper) limit of the measuring
interval might be more reliably defined, if the
2) The model consists of 11 imaginary samples with means μ
increasing from 0.5 to 10 in steps of 1. For each sample a
hundred "measurements" are performed. They are the values
of simulated independent random variables with distribution
Ν{μ, σ2}, where σ2 = (0.1 + 0.05 μ)3. The variables were
generated by Box-Mullet's transformations (p. 453 in 1 c
(15)).
threshold corresponds to the point at which an
acceptable CV-line (e.g. 10% or 15%) intersects
the confidence limit, rather than the curve itself.
ii) If, in the 3-parameter variance function one sets
the value for U to zero, the normal distribution
of the random errors of the blank will result. The
mean of the next adjacent normal distribution,
following the variance formula and overlapping
the "zero-distribution" by a defined amount, rep-
resents the limit of detection.
iii) Within the measuring interval, as described under
(i), or within a fraction of it, one might construct
overlapping normal distributions in aii analogous
manner. Their number represents the "power of
definition" (PD) (instead of the "analytical sen-
sitivity"), which also depends on the concentra-
tion of the determinand according to the variance
function.
In order to test the validity of these statements, we
shaped an artificial data base of 11 χ 10 values2) as
a model, following the function
,3.0
S
2(U) = (0.1 + 0.05 U)
The plot of variances versus concentration performed
by the Sadler-Smith-programs is shown in figure 1.
Obviously the eleven means with their corresponding
curve are enveloped in an increasingly wider band of
confidence limits. A precision profile results if, instead
of the variance, the coefficient of standard deviation
d/^/U χ 100) is scaled on the ordinate (fig. 2). The
curve declines continuously from the point of the
lowest concentration (0.5), reaching a minimum at









Fig. 1. Plot of variance (y-axis),» ias a function (F = (0.1
-f 0.05 U)3·0) of concentration (x-axis* arbitrary units)
of a model population, and 95% confidence interval,
adjusted for 100-fold measurements.
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Fig. 2. As figure 1, the variance is substituted by CV on the y-
axis. The measuring interval is given by the intersections
of a 5.5% CV line with the lower and upper edge of
the confidence interval of the CV curve.
Let F be the given overlap, e.g. 5%. In order to
determine LD in practice, we solve the equation:
F = <D{LD,a2(LD),Lc} + (1 - <D{0,a2(0),Lc})
by an iterative numerical procedure (secant method
(15)).
Here, for any μ, σ2 and Lc, we express by Φ{μ,σ2,ί0}
the area between — co and Lc under the normal
distribution Ν{μ,σ2}; and we denote by Lc the critical
limit, i. e. the ordinate of the intersection of the normal
distribution N{LD,a2(LD)} and Ν{0,σ2(0)}. We calcu-
late LC by the Newton-Raphson procedure (15).
If one accepts an overlap of 5%, the following values
result from the model described:
confidence interval increases slowly. With an accepted
CV of 5.0%, the measuring interval spreads from 1.4
to 10.4 arbitrary units.
The following procedure might be used to assess the
limit of detection by means of the variance function
according to statement (ii):
Given the mean μ and variance σ2 we write Ν{μ,σ2}
for the corresponding normal distribution. Let LD be
the concentration for which N{LD,a3(LD)} and
Ν{0,σ2(0)} overlap by a given amount, e.g. 5%
(fig. 3).
σ(0) = 0.0316, a(LD) = 0.0348,
Lc = 0.0628, LD = 0.1302.
The analytical power of definition (PD) within the
measuring interval of the model can be assessed analo-
gously: beginning with the concentration of 2.0 as the
mean, the right half of a normal distribution is con-
structed, the next distribution which yields 5% over-
lapping is connected and so on, up to the concentra-
tion of 9.0 (fig. 4). Obviously 10 normal distributions
can be inserted, when the overlapping is resticted to
5%. If an overlap of 10% would be tolerated, then








0.0 0.063 0.130 Concentration [arbitrary units]
Fig. 3. Assessment of the limit of detection: first a normal distribution is constructed, whose standard deviation corresponds to
I/O.I3 = 0.0316 (analogous to the variance formula with U = 0); the next adjacent normal distribution following the
variance formula and overlapping the zero-distribution by 5% is calculated by iterative numerical procedures; Lc: Critical
Limit, LD: Limit of Detection,
vertically hatched: O{LD,a2(LD),Lc}
horizontally hatched: 1 —
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5.0
O . O C 3.4 4.8 6 .2 7 .6 9 .0
Concentration [arbitrary units]
Fig. 4. Assessment of the power of definition: analogous to the procedure shown in figure 3: first the right half of a normal
distribution with the mean value of 2.0 is constructed, whose standard deviation corresponds to J/(0.i + 0.05 χ 2)3
= 0.089; the next adjacent distributions with overlaps of 5% between neighboring distributions are added up to the
concentration of 9.0 arbitrary units.
Practical Examples
A) Radioimmunoassay for the determina-
tion of ciclosporin in haemolysate (16)
In an evaluation of methods for the determination of
the immunsuppressive, ciclosporin, we determined in
analogous manner the lower limit of the measuring
interval (LLQ), limit of detection (LD) and the power
of definition (PD) of the immunoassay Cyclotrac SP
(Incstar Corp.) RIA.
This assay is routinely used in our laboratory for
ciclosporin determination in haemolysates from liver-
or kidney-transplanted patients. Samples from pa-
tients, not treated with cyclosporin (blanks) were not
investigated. Usually the assays are performed as trip-
licates. Out of the laboratory protocols of June—
August 92, the results of 112 triplicates are selected.
The used triplicate values are therefore within-assay-
values, and the sum of all triplicates represents be-
tween-assay-estimates. This distinction corresponds to
common usage in laboratory practice.
The 336 results were chosen randomly without elim-
ination of outliers. The database was processed by
the Sadler-Smith-pTogram. The lowest measured
value was 23 μg/l, the highest was 504 μg/l.
The variance function, according to Sadler^Smith was:
S
2(U) = (6.733 + 0.08957 U)1·601
Hence it follows:
i) Lower limit of measuring interval (fig. 5): if an
imprecision of CV = 15% is tolerated, LLQ is
given by 57 μ§/1; for a CV = 10% LLQ is 105
μg/l; (the upper limit of the measuring interval
(ULQ) cannot be assessed by the diagram).
ii) Limit of detection (fig. 6): LD equals 19.9 μg/l
with a statistical confidence of ρ > 0.95; Lc is
given by 9.3 μg/l.
25 -ι
20-
50 100 150 200 250 300
105 . Ciclosporin I/yg/l]
£
Fig. 5. Constructed as m figure 2 with the the variance function
of the cyciosporin/RIA-assay:
s2(U) = 6.73320 + 0.08957 U)1·601.
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0.0 9.3 19.9 40.0
Ciclosporin U/g/l]
Fig. 6. Constructed as in figure 3 with the the variance function
of the cyclosporin/RIA-assay:
s2(U) = (6.73320 + 0.08957 U)1·601.
iii) Power of definition (PD): within the concentra-
tion interval from 100 to 400 μ§/1, the preferred
therapeutic interval, it is possible to construct 6
normal distributions, following the variance func-
tion and with an overlap of 5% (fig. 7); the
standard deviation increases from 9.06 μg/l for
c = 100 μ^ (CV = 9.06%) to 19.9 μg/l for
c = 400 jig/1 (CV = 5.04%).
B) Fluorescence-polarization-immunoassay
for the determination of ciclosporin
in haemolysate (17)
We compared the analytical efficiency of the RIA
with the widespread TDx-Cyclosporin monoclonal
Abbott Laboratories. As with the RIA, we used the
results of another 112 triplicates, collected in a ran-
dom fashion from the printouts of the analyser, and
processed without elimination of outliers. All hae-
molysates originated from patients after kidney or
liver transplantation. Samples from patients not
treated with ciclosporin (blanks) were not investi-
gated. The lowest measured ciclosporin concentration
was 46.3 μg/l, the highest was 601.8 μg/l.
The variance function, according to Sadler-Smith was:
S
2(U) = (1.25932 + 0.00105 U)9185
hence it follows:
i) Lower limit of measuring interval, LLQ (fig. 8): if
an imprecision of CV = 10% is tolerated, LLQ is
given by 42 μg/l; for a CV = 5% LLQ is 98 μg/l;
(the upper limit of the measuring interval cannot
be assessed by the diagram).
ii) Limit of detection (fig. 9): LD equals 11.6 μg/l
with a statistical confidence of p > 0.95; Lc is
given by 5.7 μg/l.
iii) Power of definition (PD): within the concentra-
tion interval from 100 to 400 μg/l, it is possible
.ti
I.0
160.0 220.0 280.0 340.0 400.0
Ciclosporin [//g/l]
Fig. 7. Constructed as in figure 4 with the the variance function of the cyclosporin/RIA-assay:
s2(U) = (6.73320 + 0.08957 U)1·601.
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Fig. 8. Constructed as in figure 2 with the the variance function
of the cyclosporin/TDx-assay:
s2(U) = (1.25932 + 0.00105 U)9·185.
to construct 12 normal distributions, following
the variance function and with an overlap of 5%
(fig. 10); the standard deviation increases from
4.16 μ^ for c = 100 μ§/1 (CV = 4.16%) to 10.79
for c = 400 μ^ (CV = 2.70%).
Discussion
In order to assess the performance of immunoassays
one can use the variance function according to Ekins
(7) and Sadler et al. (18). Nevertheless, the dependence
of the analytical variance on the concentration of the
analyte is not restricted to immunoassays: precision
profiles from the Sadler-Smith-program can also be






Fig. 9. Constructed as in figure 3 with the the variance function
of the cyclosporin/TPx^assay:
s2(U) = (1.25932 + 0.00105 U)9·185.
parisons of sodium determinations by flame-photo-
metry and ion selective electrodes; or of measurements
of creatinine by enzymatic and Jaffe-mtthods (2), or
of determinations of cholesterol by conventional and
dry-chemistry methods (19). In recent, unpublished
studies we successfully evaluated methods for the de-
termination of cadmium by atomic absorption spec-
trometry, or lithium with ion selective electrodes in
the same way. The data, originating from patient-
material as well as from artifically spiked solutions
100.0 160.0 220.0 260.0 340,0 400,0
Ciclosporin fy/g/IJ;
Fig. 10. Constructed as in figure 4 with the the variance function of the cyclosporin/TDx-assay
s2(U) = (1.25932 + 0.00105 U)9·185.
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can all be processed by the Sadler-Smith-program
without any problems, provided an adequate number
of different measuring points is given.
Only a few authors (e. g. 1. c. (4, 7, 19» have followed
the suggestion that the limit (s) of the measuring in-
terval should be assessed by means of the precision
profile or the variance function. Nevertheless, prac-
tical experience has shown that this provides the lab-
oratory with an objective criterion for the evaluation
and a powerful tool for the judgement of the per-
formance of the methods used. The idea of defining
the measuring interval as the intersection of a CV line
with the upper edge of the CV curve confidence in-
terval is decidedly a conservative approach. In defin-
ing the limits in this manner the efficiency of the
method under investigation will certainly not to be
overestimated.
The importance of a reliable assessment of the limit
of detection (LD) for diagnostic purposes is very high
in laboratory medicine, e.g. for the verification of
intoxications, screening of drugs, control of tumour
marker concentrations, serological detection of anti-
gens or antibodies etc. In order to determine LD the
majority of clinical laboratories perform multiplicate
analyses of an analyte-free standard, and define LD
as the concentration that equals the value of three
standard deviations above zero (20). This definition
corresponds to the error distribution of the blank, it
confines the tolerated α-error, and "... probably gives
an overly optimistic estimate ... (21)" of LD. Further-
more, a blank, the matrix of which corresponds al-
most completely to the actual samples, is often diffi-
cult or even impossible to obtain for biological ma-
terial. The extrapolation from low values of real sam-
ples to the zero-value by means of the variance func-
tion seems to produce more realistic data.
For this very reason the following definition has been
proposed (18):
LD = Ζ χ SD/J/5 ,
where Z denotes the one-tailed standard normal de-
viate. It is important to emphasize that this definition
fixes the magnitude of the ^error. The approximation
of LD by the described iterative procedures, however,
makes it possible to fix the magnitude of the total
error, e. g.
α-error + -error < 5%
The fact that the calculation is more complicated is
of no importance given the high performance of mod-
ern PCs.
Also, the following should be taken into considera-
tion: in the range of low analyte concentrations all
instruments of analytical methods necessarily produce
negative signals occasionally. Modern analyser sys-
tems ("black boxes"), on the other hand, never pro-
duce negative results; many systems do not even pro-
duce zero-results. Instead, they indicate by a symbol
that the result is below a certain lower measuring-
limit, the value of which is rarely known to the user.
In order to define the LD for this kind of analytical
systems, the assessment by means of the variance
function seems to be the only possible way.
For the assessment of power of definition (PD) the
bidrectional calculation is also desirable, in order to
control α-errors and -errors simultaneously. To-
gether with the analytical variance (or STD or CV),
the PD is always changing with changes of the con-
centration. The assessment of the PD can always be
restricted to the measuring interval, or to an interval
of diagnostic interest. Knowing the specific variance
function and being able to perform the described
iterative procedures, the laboratory can construct a
special method-dependent scale, analogous to figures
4, 7, or 10 for this interval. In practice an output
device might calculate the minimal distinguishable
differences, so that the laboratory exclusively prints
out and/or documents values that differ by a defined
level of confidence.
Recently Fr ser et al. (22), again pointed out that in
order to recognize differences of concentrations at the
95% level of confidence a factor of 1.96 (or 2.58 at
the 99% confidence level) is mandatory. This means
that at a 10% CV, e.g. a difference of concentration
of 20% (or 26%) is necessary for a firm distinction.
Encompassing their "UK Cyclosporin Quality As-
sessment Scheme" (23) Holt et al. (24) have evaluated
the results of 176 participating laboratories; in sum-
mary, they stated "... the best precision was shown
by the most automated methods, that is the FPIA
TDx-SP...". Their judgement, based on an interla-
boratory survey, agrees very well with the results of
pur interassay study where the imprecision of the
automated assay is half of that for manual procedure.
Although ciclosporin has recently been prescribed in
low doses for the treatment of autoimmuno diseases,
one cannot find exact information about the limit of
detection in the literature. A recent study of Holt et
al. (25) has shown how important this knowledge
might be: laboratories (up to 38% of the participants)
reported partly high ciclosporin concentrations in a
blank specimen (without ciclosporin), given in a qual-
Bur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 7
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ity assessment study. These false-positive results re-
flect the ignorance of many laboratories about the
efficiency and performance of the methods they use.
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